You have 9 free searches left this month | for more free features.

Dupilumab

Showing 1 - 25 of 198

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Atopic Dermatitis Trial (Dupilumab - Discontinuation, Dupilumab - Dose Reduction, Dupilumab - Standard Dose)

Not yet recruiting
  • Atopic Dermatitis
  • Dupilumab - Discontinuation
  • +2 more
  • (no location specified)
Nov 2, 2023

Dupilumab in Prurigo Nodularis: An Observational Study

Not yet recruiting
  • Prurigo Nodularis
  • Dupilumab
  • (no location specified)
Aug 7, 2023

Bullous Pemphigoid Trial (dupilumab)

Temporarily not available
  • Bullous Pemphigoid
  • dupilumab
  • (no location specified)
Jun 7, 2023

Dermal Hypersensitivity Reaction Trial in Ann Arbor (Dupilumab)

Not yet recruiting
  • Dermal Hypersensitivity Reaction
  • Dupilumab
  • Ann Arbor, Michigan
    University of Michigan
Aug 21, 2023

Chronic Rhinosinusitis With Nasal Polyps Trial in Charleston, Charlottesville (Dupilumab)

Recruiting
  • Chronic Rhinosinusitis With Nasal Polyps
  • Dupilumab
  • Charleston, South Carolina
  • +1 more
Jul 27, 2023

Atopic Dermatitis Trial in San Francisco (Dupilumab)

Recruiting
  • Atopic Dermatitis
  • Dupilumab
  • San Francisco, California
    University of California, San Francisco
May 4, 2023

NSCLC Trial (Dupilumab, Cemiplimab)

Not yet recruiting
  • Non-Small Cell Lung Cancer
  • Dupilumab
  • Cemiplimab
  • (no location specified)
Oct 12, 2023

Atopic Dermatitis, Atopic Dermatitis Eczema Trial in Rotterdam (Dupilumab)

Not yet recruiting
  • Atopic Dermatitis
  • Atopic Dermatitis Eczema
  • Dupilumab
  • Rotterdam, Zuid-Holland, Netherlands
    Erasmus Medical Center
Aug 22, 2023

Eosinophilic Oesophagitis Trial (Dupilumab, Placebo)

Not yet recruiting
  • Eosinophilic Oesophagitis
  • Dupilumab
  • Placebo
  • (no location specified)
Oct 19, 2023

Healthy Volunteer Trial in Saint Paul, Springfield (Dupilumab (SAR231893))

Completed
  • Healthy Volunteer
  • Dupilumab (SAR231893)
  • Saint Paul, Minnesota
  • +1 more
Jul 28, 2023

Prurigo Nodularis Trial (Dupilumab SAR231893 (REGN668))

Not yet recruiting
  • Prurigo Nodularis
  • Dupilumab SAR231893 (REGN668)
  • (no location specified)
Oct 11, 2023

Eosinophilic Gastritis, Eosinophilic Duodenitis, Eosinophilic Gastrointestinal Disease Trial (Dupilumab Dose 1, Dupilumab Dose

Not yet recruiting
  • Eosinophilic Gastritis
  • +2 more
  • Dupilumab Dose 1
  • +2 more
  • (no location specified)
Apr 14, 2023

Healthy Volunteers Trial in Miami (Dupilumab (SAR231893))

Completed
  • Healthy Volunteers
  • Dupilumab (SAR231893)
  • Miami, Florida
    Clinical Pharmacology of Miami-Site Number:8400001
Jul 28, 2023

Healthy Volunteers Trial in Saint Paul (Dupilumab (SAR231893))

Completed
  • Healthy Volunteers
  • Dupilumab (SAR231893)
  • Saint Paul, Minnesota
    Prism Research-Site Number:840001
Jul 28, 2023

Bronchial Inflammation, Small Airways Disfunction and Mucous

Not yet recruiting
  • Asthma; Eosinophilic
  • Dupilumab
  • (no location specified)
Mar 15, 2023

Skin Diseases Trial in Chicago (Dupilumab)

Not yet recruiting
  • Skin Diseases
  • Dupilumab
  • Chicago, Illinois
    Ann & Robert H. Lurie Children's Hospital of Chicago
Jan 9, 2023

Dermatitis Atopic Trial (dupilumab)

Not yet recruiting
  • Dermatitis Atopic
  • dupilumab
  • (no location specified)
Aug 1, 2023

Asthma, Allergic Trial in San Antonio (Dupilumab, House Dust Mites (HDM), Placebo)

Not yet recruiting
  • Asthma, Allergic
  • Dupilumab
  • +2 more
  • San Antonio, Texas
  • +1 more
Jan 27, 2023

Atopic Dermatitis, Atopic Dermatitis Eczema, Eczema Trial in San Francisco (Dupilumab)

Recruiting
  • Atopic Dermatitis
  • +3 more
  • Dupilumab
  • San Francisco, California
    UCSF Psoriasis and Skin Treatment Center
Jan 25, 2023

Quality of Life in Male and Female Adult Severe Asthma Treated

Not yet recruiting
  • Asthma
    • (no location specified)
    Aug 31, 2023

    Alopecia Areata Trial in United States (Dupilumab, Placebo)

    Not yet recruiting
    • Alopecia Areata
    • Dupilumab
    • Placebo
    • Irvine, California
    • +3 more
    May 10, 2023

    Dupilumab in Participants =6 Years With Atopic Dermatitis

    Recruiting
    • Atopic Dermatitis
      • Berlin, Germany
        Investigational Site Number :
      Sep 18, 2023

      Atopic Dermatitis Trial in Newark (BSI-045B, Dupilumab)

      Not yet recruiting
      • Atopic Dermatitis
      • Newark, Delaware
        Biosion USA, Inc.
      Jul 7, 2023

      Describe Post-authorisation Early Clinical Experience of

      Active, not recruiting
      • Asthma
      • No intervention
      • Chilly-Mazarin, France
        Investigational Site Number :
      Sep 26, 2023

      Pruritus Trial in Jacksonville (Dupilumab 300Mg Solution for Injection)

      Recruiting
      • Pruritus
      • Dupilumab 300Mg Solution for Injection
      • Jacksonville, Florida
        Mayo Clinic Florida
      Nov 30, 2022